Your browser doesn't support javascript.
loading
Patiromer to Enable Spironolactone in Patients with Resistant Hypertension and CKD (AMBER): Results in the Prespecified Subgroup with Diabetes.
Agarwal, Rajiv; Rossignol, Patrick; Mayo, Martha R; Conrad, Ansgar; Arthur, Susan; Williams, Bryan; White, William B.
Afiliação
  • Agarwal R; Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana.
  • Rossignol P; Inserm 1433 CIC-P CHRU de Nancy, Inserm U1116 and FCRIN INI-CRCT,, University of Lorraine, Nancy, France.
  • Mayo MR; Clinical Development, Vifor Pharma, Inc, Redwood City, California.
  • Conrad A; Medical Affairs, Vifor Pharma, Inc., Redwood City, California.
  • Arthur S; Biostatistics, Vifor Pharma, Inc., Redwood City, California.
  • Williams B; Department of Medicine, Institute of Cardiovascular Sciences, University College London (UCL) and National Institute for Health Research (NIHR) UCL/UCL Hospitals Biomedical Research Centre, London, United Kingdom.
  • White WB; Calhoun Cardiology Center, University of Connecticut School of Medicine, Farmington, Connecticut.
Clin J Am Soc Nephrol ; 16(9): 1407-1409, 2021 09.
Article em En | MEDLINE | ID: mdl-34162695
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Polímeros / Espironolactona / Hipertensão Limite: Humans Idioma: En Revista: Clin J Am Soc Nephrol Assunto da revista: NEFROLOGIA Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Polímeros / Espironolactona / Hipertensão Limite: Humans Idioma: En Revista: Clin J Am Soc Nephrol Assunto da revista: NEFROLOGIA Ano de publicação: 2021 Tipo de documento: Article